SciSparc (SPRC) Profit After Tax (2016 - 2022)
SciSparc (SPRC) posted Profit After Tax of $2.1 million for Q4 2022, up 139.62% sequentially from -$5.2 million in Q3 2022.
SciSparc (SPRC) Profit After Tax (2016 - 2022) Analysis & Trends
SciSparc has reported Profit After Tax for 5 years, with the latest figure at $2.1 million in Q4 2022.
- Quarterly Profit After Tax changed N/A year-over-year to $2.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$646000.0 (changed N/A YoY) and the FY2025 annual result came in at -$12.6 million, down 68.15% from the prior year.
- Profit After Tax improved to $2.1 million in Q4 2022 per SPRC's latest filing, from -$5.2 million in the prior quarter.
- Over five years, Profit After Tax peaked at $2.1 million in Q1 2019 and troughed at -$12.3 million in Q4 2018.
- A 3-year average of -$1.4 million and a median of $764500.0 in 2018 frame the typical range for Profit After Tax.
- The widest YoY moves for Profit After Tax: up 222.01% in 2018, down 354.79% in 2018.
- Over 3 years, Profit After Tax stood at -$12.3 million in 2018, then jumped by 103.12% to $385000.0 in 2019, then surged by 439.74% to $2.1 million in 2022.
- According to Business Quant data, Profit After Tax over the past three periods registered $2.1 million, -$5.2 million, and $385000.0 for Q4 2022, Q3 2022, and Q2 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.08 Mn |
| Sep 30, 2022 | -5.25 Mn |
| Jun 30, 2019 | 385,000.00 |
| Mar 31, 2019 | 2.14 Mn |
| Dec 31, 2018 | -12.33 Mn |
| Sep 30, 2018 | 1.14 Mn |
| Jun 30, 2018 | -1.21 Mn |
| Mar 31, 2018 | 2.05 Mn |
| Dec 31, 2017 | -2.71 Mn |
| Sep 30, 2017 | -1.03 Mn |
| Jun 30, 2017 | -1.86 Mn |
| Mar 31, 2017 | 636,000.00 |
| Dec 31, 2016 | 3.59 Mn |
| Sep 30, 2016 | -536,000.00 |
| Jun 30, 2016 | 543,000.00 |